Jump to content

Search the hub

Showing results for tags 'Allergies'.


More search options

  • Search By Tags

    Start to type the tag you want to use, then select from the list.

  • Search By Author

Content Type


Forums

  • All
    • Commissioning, service provision and innovation in health and care
    • Coronavirus (COVID-19)
    • Culture
    • Digital health and care service provision
    • Improving patient safety
    • Investigations, risk management and legal issues
    • Leadership for patient safety
    • Organisations linked to patient safety (UK and beyond)
    • Patient engagement
    • Patient safety in health and care
    • Patient Safety Learning
    • Professionalising patient safety
    • Research, data and insight
    • Miscellaneous

Categories

  • Commissioning, service provision and innovation in health and care
    • Commissioning and funding patient safety
    • Health records and plans
    • Innovation programmes in health and care
    • Climate change/sustainability
  • Coronavirus (COVID-19)
    • Blogs
    • Data, research and statistics
    • Frontline insights during the pandemic
    • Good practice and useful resources
    • Guidance
    • Mental health
    • Exit strategies
    • Patient recovery
    • Questions around Government governance
  • Culture
    • Bullying and fear
    • Good practice
    • Occupational health and safety
    • Safety culture programmes
    • Second victim
    • Speak Up Guardians
    • Staff safety
    • Whistle blowing
  • Digital health and care service provision
    • Artificial Intelligence
    • Apps for health and care
    • Teleservices
    • Other health and care software
    • Digital health regulatory bodies/standards/guidance
  • Improving patient safety
    • Clinical governance and audits
    • Design for safety
    • Disasters averted/near misses
    • Equipment and facilities
    • Error traps
    • Health inequalities
    • Human factors (improving human performance in care delivery)
    • Improving systems of care
    • Implementation of improvements
    • International development and humanitarian
    • Patient Safety Alerts
    • Safety stories
    • Stories from the front line
    • Transformative Simulation
    • Workforce and resources
  • Investigations, risk management and legal issues
    • Investigations and complaints
    • Risk management and legal issues
  • Leadership for patient safety
    • Business case for patient safety
    • Boards
    • Clinical leadership
    • Exec teams
    • Inquiries
    • International reports
    • National/Governmental
    • Patient Safety Commissioner
    • Quality and safety reports
    • Techniques
    • Other
  • Organisations linked to patient safety (UK and beyond)
    • Government and ALB direction and guidance
    • International patient safety
    • Regulators and their regulations
  • Patient engagement
    • Consent and privacy
    • Harmed care patient pathways/post-incident pathways
    • How to engage for patient safety
    • Keeping patients safe
    • Patient-centred care
    • Patient Safety Partners
    • Patient stories
  • Patient safety in health and care
    • Care settings
    • Conditions
    • Diagnosis
    • High risk areas
    • Learning disabilities
    • Medication
    • Mental health
    • Men's health
    • Patient management
    • Social care
    • Transitions of care
    • Women's health
  • Patient Safety Learning
    • Patient Safety Learning documents
    • Patient Safety Standards
    • 2-minute Tuesdays
    • Patient Safety Learning Annual Conference 2019
    • Patient Safety Learning Annual Conference 2018
    • Patient Safety Learning Awards 2019
    • Patient Safety Learning Interviews
    • Patient Safety Learning webinars
  • Professionalising patient safety
    • Accreditation for patient safety
    • Competency framework
    • Medical students
    • Patient safety standards
    • Training & education
  • Research, data and insight
  • Miscellaneous

News

  • News

Find results in...

Find results that contain...


Date Created

  • Start
    End

Last updated

  • Start
    End

Filter by number of...

Joined

  • Start

    End


Group


First name


Last name


Country


About me


Organisation


Role

Found 57 results
  1. Content Article
    Understanding a new medical condition can be overwhelming, and navigating the process of seeking diagnosis and specialist care can feel complex. That’s why Allergy UK have created the Allergy Self-Help Hub. It’s your first stop for understanding allergies, preparing for the journey ahead, and equipping yourself with the tools and knowledge to navigate the process. With these resources, you’ll be ready to make the most of your interactions with healthcare professionals and ensure you get the support and treatment you need.
  2. News Article
    The government must improve allergy prevention, diagnosis, and management, according to a group of charities, doctors, and patients, who say the UK has some of the highest allergy rates in the world. The group, which has found that allergies affect 39% of children and 30% of adults in the UK, has developed a National Allergy Strategy, which was presented to Westminster this week. The strategy, which is the first UK-wide framework for improving allergy care, aims to tackle "decades of policy neglect", according to the National Allergy Strategy Group (NASG). It aims to improve awareness and governance of allergies, such as asthma, hay fever, food and drug allergies, and calls for all four UK governments and the NHS to recognise allergic disease as a major long-term condition. “For too long, despite the scale of the problem, too little has been done to develop solutions,” said NASG chair Professor Adam Fox. “This strategy focuses on system-level change, embedding allergy into national policy, strengthening safety in everyday environments and improving accountability across health, education, food and workplace settings”. Read full story Source: ITV, 20 April 2026
  3. Content Article
    The National Allergy Strategy represents the first coordinated UK‑wide framework for improving allergy prevention, diagnosis, management and patient safety. It has been shaped through extensive consultation across the allergy community, including clinicians, patients and charities, and reflects both lived experience and frontline clinical realities. The strategy outlines the key objectives and priority projects needed to improve health outcomes and other unmet needs of the allergy community across the UK. The National Allergy Strategy Group (NASG) is an alliance of the professional organisations BSACI (British Society of Allergy and Clinical Immunology) and the patient charities, Allergy UK, Anaphylaxis UK and Natasha Allergy Research Foundation (NARF). Intended outcomes Reduced preventable harm, including fewer avoidable deaths and severe allergic reactions, through safer environments and earlier, more consistent intervention. Improved health outcomes and quality of life for people living with allergic disease, with greater safety, inclusion and confidence in everyday life. Reduced health and social inequalities, ensuring protection, access to care and quality of support do not depend on geography, background or individual advocacy. Equitable access to high-quality, lifelong allergy care across all four nations, supported by consistent standards, safer transitions between services, and timely access to effective treatments. A sustainable, skilled workforce and system capability, with allergy embedded in service planning, professional education and community provision to meet growing need. Better value for money for the NHS and wider public services, achieved through prevention, early intervention, improved data and surveillance, and more efficient use of resources. Further reading on the hub: Reducing the risk of your child having a serious allergic reaction: Parent and carer leaflet Why allergies are the Cinderella service of the NHS – a blog by Tim McLachlan
  4. Content Article
    Families who have lost loved ones to food allergies have come together to launch a landmark report exposing critical failings in the UK coronial system, and call for urgent action to prevent future deaths from anaphylaxis. The report, carried out in collaboration with The Natasha Allergy Research Foundation, reveals that the lives of people with severe food allergies are being put at risk because the UK is failing to learn lessons from coroners’ investigations. Coroners serve a vital role in society by providing independent, transparent investigations into sudden, unexplained, or unnatural deaths, so that lessons can be learned to prevent future deaths. Yet the new report reveals that while food allergy related deaths by their very nature are sudden and unexpected, not all result in an inquest. On average, only two Prevention of Future Deaths (PFD) reports involving anaphylaxis are issued each year. 40% of organisations fail to respond to PFD reports within the statutory 56 days. 52% take no action following a report. No statistics are collected to determine how many deaths are investigated by coroners that involve the most severe allergic reaction, anaphylaxis. These findings show that the current inquest system is inadequate to prevent repeated tragedies. The report calls for urgent reforms to the inquest system, including: A statutory national database of all deaths investigated by coroners. Mandatory coroner investigations for all anaphylaxis deaths. Parliamentary oversight to ensure responses to PFD reports are transparent and accountable. Appointment of an Allergy Tsar, a national allergy champion to drive change. Mandatory national reporting of all anaphylactic events, including near-fatal reactions. Related reading on the hub: Why allergies are the Cinderella service of the NHS – a blog by Tim McLachlan Prevention of Future Deaths Report: Celia Marsh (21 November 2022)
  5. Community Post
    NHS hospital staff spend countless hours capturing data in electronic prescribing and medicines administration systems. Yet that data remains difficult to access and use to support patient care. This is a tremendous opportunity to improve patient safety, drive efficiencies and save time for frontline staff. I have just published a post about this challenge and Triscribe's solution. I would love to hear any comments or feedback on the topic... How could we use this information better? What are hospitals already doing? Where are the gaps? Thanks
  6. Content Article
    Food allergy affects around 7-8% of children worldwide, or about two children in an average-sized classroom. As children spend at least 20% of their waking hours in school, it is not surprising that data show that 18% of food allergy reactions and 25% of first-time anaphylactic reactions occur at school. This report by the Benedict Blythe Foundations looks at the prevalence and seriousness of allergies in school-aged children, and the devastating consequences when things go wrong at school. The report makes a number of recommendations to improve the safety of children with food allergies in UK schools, including changes to the law. The report recommends: 1. Making it mandatory for all schools: to have an allergy policy, including an anaphylaxis plan for pupils with food allergies, an IHP and anaphylaxis action plan completed (and regularly updated) collaboratively by the child, parents/carers and school staff to hold spare AAIs that are in-date to implement training for school staff and teachers on allergies and anaphylaxis and a whole school allergy awareness approach 2. Government funding for the additional cost to schools for AAIs and training 3. DfE/FSA commissioned research into the effectiveness of approaches and interventions to optimise the preparedness of schools for preventing allergic reactions and managing anaphylaxis 4. Adherence to these measures to be checked as part of schools’ assessments by Ofsted
  7. Content Article
    Allergic reactions vary in severity. People with food allergy tend to have reactions which affect the skin or gut, but around one third of reactions involve the breathing: these more serious allergic reactions are known as anaphylaxis. Very rarely, anaphylaxis can be severe and therefore life-threatening. This leaflet created by Allergy UK and Anaphylaxis UK explains how you can reduce the risk of this happening. Anaphylaxis is unpredictable and can occur in people who have never had this type of reaction before, but most people will recover fully. 
  8. News Article
    Only 60% of patients who have had hospital treatment for food anaphylaxis were prescribed medicine to tackle another reaction, a study has found. The study of some 130,000 NHS records where food allergy was mentioned showed 3,589 patients received "unplanned hospital treatment" for anaphylaxis. Of those, only 2,152 were prescribed adrenaline auto-injectors (AAI) at least once. Two leading allergy specialists have produced guidance to raise awareness. Clinical scientist Dr Paul Turner from the National Heart & Lung Institute at Imperial College London, who carried out the study, and Prof Adam Fox, consultant paediatric allergist at Evelina London Children's Hospital, said they hoped the leaflet they have produced would save lives. It is designed to help patients, parents, families, grandparents, friends and nannies so they feel empowered and more confident when looking after a person with food allergies. Read full story Source: BBC News, 6 October 2023
  9. News Article
    Millions of people wrongly believe they are allergic to penicillin, which could mean they take longer to recover after an infection, pharmacists say. About four million people in the UK have the drug allergy on their medical record - but when tested, 90% of them are not allergic, research suggests. The Royal Pharmaceutical Society says many people confuse antibiotic side-effects with an allergic reaction. Common allergic symptoms include itchy skin, a raised rash and swelling. Nausea, breathlessness, coughing, diarrhoea and a runny nose are some of the others. But antibiotics, which treat bacterial infections, can themselves cause nausea or diarrhoea and the underlying infection can also lead to a rash. And this means people often mistakenly believe they are allergic to penicillin, which is in many good, common antibiotics. These are used to treat chest, skin and urinary tract infections - but if people are labelled allergic, they are given second-choice antibiotics, which can be less effective. Read full story Source: BBC News, 28 September 2023
  10. News Article
    Dangerous allergic reactions are rising in England and now cause some 25,000 NHS hospital stays a year, according to data gathered by the NHS and analysed by the Medicines and Healthcare products Regulatory Agency. Health officials say the rate has more than doubled over 20 years, prompting them to issue advice reminding people how to recognise allergies and respond. For severe food-related allergic reactions, the rise in admissions is even greater. The figures suggest anaphylaxis is on the increase, though some of the rise could be attributed to the growth in population. Anaphylaxis can be fatal and develop suddenly at any age. People who know they are at risk should always carry two adrenaline pens which they, or someone else, can administer in an emergency. In addition, people at risk of an anaphylactic reaction should regularly check the contents of their adrenaline pens have not expired. They should see a pharmacist to get a new one if a pen is close to expiring. Read full story Source: BBC News, 28 July 2023
  11. Content Article
    Pharmaswiss Česka republika s.r.o. and distributor Bausch & Lomb UK Limited is recalling all unexpired batches of Emerade 500 micrograms and Emerade 300 micrograms adrenaline auto-injectors (also referred to as pens) from patients. This is due to an issue identified during an ISO 11608 Design Assessment study where some auto-injectors failed to deliver the product or activated prematurely. Specifically, the 1-metre free-fall (vertical orientation) pre-conditioning resulted in damage to internal components of the auto-injector, leading either to failure to deliver the product or premature activation. This damage was not visibly apparent following the pre-conditioning but was evident only on subsequent functional testing. It is unclear what impact this has on auto-injectors in clinical use, however as a precautionary measure and owing to the inability to identify this issue before the auto-injectors are used, the auto-injectors are being recalled. Healthcare professionals should inform patients, or carers of patients, who carry Emerade 300 or 500 microgram auto-injector pens to obtain a prescription for and be supplied with an alternative brand. They should then be informed to return their Emerade 300 or 500 microgram pens to their local pharmacy.
  12. Content Article
    On 22 May 2021, 17-year-old Alexandra Briess underwent a tonsillectomy and subsequently experienced post-operative bleeding, requiring second operation carried out at Royal Berkshire Hospital on the 30 May. During anaesthesia, she experienced a sudden deterioration and cardiac arrest. Despite extensive resuscitation efforts, Alexandra died on the 31 May. Subsequent investigations have revealed that the most likely cause of her sudden deterioration was an anaphylactic reaction to Rocuronium. In this report, the Coroner highlights connections between this case and three other Prevention of Future Deaths Report’s and suggests there needs to be greater funding and a role within the NHS to coordinate a national approach to prevent/reduce future deaths. The report highlights three other cases where similar concerns have been raised: Shante Turay-Thomas Ruben Bousquet Celia Marsh The Coroner states that it seems clear in all these cases, that the only way to improve understanding and prevent or reduce future deaths is to gather information nationally and fund appropriate research. Coroner’s Matters of Concern There is significant goodwill and desire to improve amongst numerous organisations involved in anaphylaxis work. What is lacking is national leadership and funding. In my view, consideration should be given to creating a leadership role and responsibility within NHS England to coordinate a national approach. As considered by other coroners before me, it should be mandatory to refer fatal anaphylaxis cases. UK Fatal Anaphylaxis Registry (UKFAR) has indicated that they would be prepared to take on the role of receiving these reports (to avoid duplication for reporting clinicians), with the responsibility to forward the relevant information to other organisations such as the Medicines and Healthcare products Regulatory Agency (MHRA), where appropriate. Whilst my focus is on fatal anaphylaxis, inclusion of non-fatal cases would be a matter for the lead role to consider. Gathering data and using this to research and reduce the risk of future deaths requires funding, and this should be reviewed. Information sharing amongst the organisations referred to in this report should be straightforward. Confidentiality constraints are important, but not the same in the case of a deceased person as they are for a living person. I believe that a confidential advisory group has already started to consider this matter. Consideration of including contact details for the UKFAR in algorithms used by doctors attempting to resuscitate patients – so that there is a clear requirement for referral to UKFAR in the event of an unsuccessful resuscitation. This is currently being considered by the Resuscitation Council UK.
  13. News Article
    People with allergies and pregnant women can now be given the country’s two approved COVID-19 vaccines, the medical regulator said on Wednesday. Previous advice from the Medicines and Healthcare products Regulatory Agency (MHRA) said people with a range of allergies to food and medicines should not be given the Pfizer vaccine. Dr June Raine, the MHRA’s chief executive, said growing evidence from a pool of at least 800,000 people in the UK and around 1.5 million people in the US who have had the vaccine has "raised no additional concerns". This, she continued, "gives us further assurance that the risk of anaphylaxis can be managed through standard clinical guidance and an observation period following vaccination of at least 15 minutes. Read full story Source: The Independent, 30 December 2020
  14. News Article
    The UK’s drug regulator has warned that people with have a history of “significant” allergic reactions should not receive the Pfizer-BioNTech vaccine. The Medicines and Healthcare products Regulatory Agency (MHRA) issued the warning after two NHS staff members who were administered with doses on Tuesday both suffered an allergic reaction. NHS England said all trusts involved with the vaccination programme have been informed. Dr June Raine, chief executive of the MHRA, said the regulatory body was examining the cases. “We know from the very extensive clinical trials this wasn’t a feature," she told a parliamentary committee on Wednesday. "But if we need to strengthen our advice now that we’ve had this experience in the vulnerable populations - the groups that have been selected as a priority - we get that advice to the field immediately.” Read full story Source: The Independent, 8 December 2020
  15. News Article
    A teenager with a severe nut allergy died in part because of human error, a coroner has ruled. Shante Turay-Thomas, 18, had a severe reaction to eating a hazelnut. The inquest heard a series of failures meant that an ambulance took more than 40 minutes to arrive at her home in Wood Green, north London. Her mother Emma Turay, who said she felt "badly let down" by the NHS, wants an "allergy tsar" to be appointed to help prevent similar deaths. The inquest heard call staff for the NHS's 111 non-emergency number failed to appreciate the teenager's worsening condition was typical of a severe allergic reaction to nuts. A telephone recording of the 111 call, made by her mother, at 23:01 BST on Friday 14 September 2018, revealed how the 18-year-old could be heard in the background struggling to breathe. "My chest hurts, my throat is closing and I feel like I'm going to pass out," she said before asking her mother to check how long the ambulance would be, then adding: "I'm going to die." The inquest heard Ms Turay-Thomas had tried to use her auto-injector adrenaline pen, however it later emerged she had only injected a 300 microgram dose, rather than the 1,000 micrograms needed to stabilise her condition. It also emerged she was unaware of the need to use two shots for the most serious allergic reactions and had not received medical training after changing her medication delivery system from the EpiPen to a new Emerade device. The inquest at St Pancras Coroner's Court was told an ambulance that was on its way to the patient had been rerouted because the call was incorrectly categorised as requiring only a category two response, rather than the more serious category one. Read full story Source: BBC News, 13 January 2020
  16. Content Article
    This free online e-learning course is designed for parents and carers of severely allergic children. This course aims to improve and update knowledge about the everyday management of severe allergies. Topics include: What happens in an anaphylactic reaction Early recognition of the signs and symptoms of anaphylaxis How and when to use adrenaline injectors, and how to care for these devices Crisis management The long-term management, such as avoidance of allergens What you need to know to lessen the risk of a severe allergic reaction Food labelling regulations in the UK and Europe The role of parents and carers in enabling schools to support children who have severe allergies. Individuals can work through this course at their own pace, it will take around 1 hour to complete. Upon successful completion of this AllergyWise course (75% pass rate) you can buy a certificate for £5 plus VAT for proof. To register please follow the link below.
  17. Content Article
    This study from Baseggio Conrado et al. describe time trends for hospital admissions due to food anaphylaxis in the United Kingdom over the past 20 years. The authors found that hospital admissions for food induced anaphylaxis have increased from 1998 to 2018, however the case fatality rate has decreased. In school aged children, cow’s milk is now the most common single cause of fatal anaphylaxis.
  18. Content Article
    The purpose of this study from Roberts et al. was to explore anxiety, worry, and posttraumatic stress symptoms (PTSS) in parents of children with food allergies, and to evaluate whether these three psychological outcomes could be predicted by allergy severity, intolerance of uncertainty, and food allergy self-efficacy. The study highlights the need for greater awareness of mental health in parents of children with food allergy. 
  19. Content Article
    In this blog for the hub, Tim McLachlan, Chief Executive of the Natasha Allergy Research Foundation, highlights the lack of support available for patients and their families who spend their lives trying to keep either themselves or their children safe. To date there has been little attention, importance and investment given to NHS allergy services and this, he says, needs to change. Having a child with a food allergy can have a devastating effect on all of the family. Research by the University of East Anglia last month (March) revealed that almost half (42%) of parents of children living with food allergies have suffered trauma that meets the criteria for post-traumatic stress symptoms.[1] It’s a shocking figure, but perhaps not surprising. Between 6 and 8% of children have a food allergy, with the most common being eggs, milk and peanuts. The number of people admitted to hospital for severe food allergies has tripled over the past two decades according to research published in the BMJ this year.[2] Deaths are thankfully rare but watching your child have a potentially life-threatening reaction to a food is harrowing. Then there is the day-to-day constant vigilance to try to avoid the allergen that could cause a reaction, the anxiety of not knowing when the next allergic reaction will occur and whether the prescribed EpiPen to counter a reaction will work. The uncertainty is huge. Yet there is surprisingly little support for these parents who spend their lives trying to keep either themselves (if they have a food allergy) or their children safe. The Natasha Allergy Research Foundation was formed in 2019 to improve the lives of the 2 to 3 million people in the UK who have a food allergy and their families. It was set up by the parents of Natasha Ednan-Laperouse who died aged 15 in 2016 after having an allergic reaction to an ingredient hidden in a baguette. The charity focuses on medical research as well as education and raising awareness of food allergies. Natasha’s parents, Tanya and Nadim, have also successfully campaigned for Natasha’s Law, which requires businesses to provide a full list of ingredients on pre-packaged food made and sold on the same premises, such as salads and sandwiches, from this October. They know only too well the challenges of caring for a child with a severe food allergy and are alarmed at the lack of support available to families. Natasha had her first allergic reaction when she was six months old, when she ate a small amount of banana which caused her lips to swell until they split. "She was screaming, it was just awful," recalls Tanya. "The second time, when she had formula milk, she looked like she’d been dropped into a vat of hot oil. Her skin was raised and bright red and she was in complete distress." Even if you’re an adult or a child who hasn’t had an anaphylactic reaction, knowing it is a possibility causes huge amounts of stress. "Worrying about something can often be worse than actually having to deal with it because it never leaves your side," adds Tanya. "You’re in a constant state of hypervigilance but trying to lead a normal life because the last thing you ever want to do is to actually become someone who micromanages everything as that’s no way to live either." Part of the problem is that there are not enough trained allergists in this country, the charity says. GP training in allergies is also patchy, so while some patients and their families get the support they need, others are left to cope on their own. "We know from our supporters that many people with food allergies feel they are forgotten and alone," says Tanya. "They find it hard to get the care and support they need and, in some cases, to have their condition taken seriously. This has to change." Despite the growing number of people with a food allergy, allergy remains a Cinderella service in the NHS; there has been little attention, importance and investment given to NHS allergy services despite a number of reports since 2003 by allergy experts and MPs calling for better care for people with allergic disease. "Many GPs receive no training in allergies which can be complex conditions. There is also a shortage of allergy specialists in the UK and allergy training. As a result, the care people with allergies receive is at best patchy, and at worst has led to avoidable deaths. Without greater priority given to allergies, these problems will continue and sadly more lives will be lost unnecessarily," adds Tanya. To find out more about Natasha’s Army (to receive regular updates on the work of the Foundation) go to www.narf.org.uk. References Roberts K, Meiser-Stedman R, Brightwell A, Young J. Parental Anxiety and Posttraumatic Stress Symptoms in Pediatric Food Allergy. J Pediatr Psych 2021; https://doi.org/10.1093/jpepsy/jsab012. Baseggio Conrado A, Ierodiakonou D, Gowland MH, et al. Food anaphylaxis in the United Kingdom: analysis of national data, 1998-2018. BMJ 2021;372. R
  20. Content Article
    The Natasha Allergy Research Foundation (NARF) has added its voice to a chorus of growing safety concerns about the rise in businesses operating out of people’s homes. NARF said urgent government intervention on food safety standards is required to deal with the subject that has gained increased attention during the coronavirus pandemic. Tanya Ednan-Laperouse, founder of Natasha’s Foundation, said the emergence of tens of thousands of at-home and dark kitchens during the COVID-19 pandemic raises fears about food safety, particularly for the two million plus people in the UK who have food allergies. “...we need ministerial intervention, laws to ensure businesses are regulated, inspected and rated, and an urgent commitment to boost resources targeted at food safety. The cost of failure for many families will be too high.” The Foundation was set up by the parents of Natasha Ednan-Laperouse who died in 2016 after an allergic reaction to sesame in a baguette. It has been instrumental in new labeling legislation, called Natasha’s Law, that will come into force in the UK beginning in October.
  21. Content Article
    People with severe food allergies should carry two adrenaline autoinjector pens with them at all times, according to new guidance. Updated advice from The National Institute for Health and Care Excellence (NICE) says healthcare professionals should always offer people with severe allergies a prescription for two adrenaline auto-injectors (AAIs), which deliver potentially life-saving doses of the hormone to treat anaphylaxis, before being discharged from hospital after emergency treatment. They should also advise patients to always carry two devices with them, the guidance states.
  22. News Article
    One of the main brands of adrenaline auto-injector pen, which can save lives during serious allergy attacks, is being recalled in the UK after the death of a teenager whose family say the product failed. Shante Turay-Thomas, 18, died in September last year after it is claimed that her adrenaline pen did not work although she tried it twice. She told her mother, “I’m going to die,” as she succumbed to an allergic reaction to hazelnuts. Her death was the subject of an inquest hearing last month, which resumes this week. The Medicines and Healthcare products Regulatory Agency (MHRA) confirmed this weekend that all batches of Emerade auto-injector had been recalled from pharmacies after an error was identified that can cause some pens to fail to activate. Between July and November, the agency said it had been made aware of 16 suspected activation failures. The agency said it was aware of two fatalities of patients reported to have used the pens but the fault had not been confirmed as a contributor to the deaths. Read full story Source: The Times, 8 December 2019
  23. Content Article
    A deep learning algorithm accurately identified allergic reactions in hospital patient safety reports, which could help providers avoid medical errors and improve event surveillance, according to a study from Yang et al. published in JAMA Network Open. Allergic reactions – to medications, foods, and healthcare products – are becoming increasingly common in the US. Researchers noted that up to 36% of patients report drug allergies, and 4-10% report food allergies. Patients in healthcare settings are at particularly high risk of developing an allergic reaction, and it’s critical that providers are able to quickly detect and monitor these events. Results of this study suggest that deep learning can improve the accuracy and efficiency of the allergic reaction identification process, which may facilitate future real-time patient safety surveillance and guidance for medical errors and system improvement.
  24. Content Article
    The Patient Safety Authority has put together information and tips for patients on a range of topics. C-Diff Dentures in the healthcare setting Discharge instructions Drug allergies End of life care Falls at home Getting the right diagnosis Handwashing Hospital ratings Influenza (the flu) Latex allergies Medical records Medication safety at home Medication safety: Hospital and doctor's office Metric-based patient weights MRI safety MRSA Neonatal abstinence syndrome (NAS) Norovirus (stomach flu) Obstructive sleep apneoa Pneumonia Pressure injuries (bed sores) Sepsis What is an MRI? Wrong-site surgery
  25. News Article
    The parents of a teenage girl who died from an allergic reaction to a Pret a Manger baguette have set up a clinical trial to make "food allergies history". Nadim and Tanya Ednan-Laperouse's daughter Natasha, 15, died in 2016 after eating a baguette containing sesame, to which she was allergic. The trial will investigate if everyday food products can be used as treatment. It is a unique opportunity to establish immunotherapy as a practical treatment, according to an expert. The trial, set up by the family from Fulham in west London, will see whether commonly available food products, such as milk and peanuts, can be used under medical supervision to treat those with food allergies. After a 12-month desensitisation period, those involved will be tracked for two further years. Mr and Mrs Ednan-Laperouse's daughter died in 2016 after she ate an artichoke, olive and tapenade baguette containing sesame seeds, bought from a Pret a Manger at Heathrow Airport. The wrapper did not have any allergy information, and, as it was made on the premises, this was not required by law at the time. In October, "Natasha's Law" was brought in, making allergy information a requirement for food made on site. Read full story Source: BBC News, 18 May 2022 Related articles on the hub Why allergies are the Cinderella service of the NHS – a blog by Tim McLachlan
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.